Free Webinars – Overview

In this webinar, learn about the negative effects of culturing cells in serum and the advantages of switching to serum-free cell culturing.

An Assessment of Cryopreservation Impact on T-Cell Activation and Phenotype.

This webinar provides you with tips and hints to start or improve your primary cell culture.

Watch our team demonstrate the 4D-Nucleofector^® LV Unit for efficient large-scale electroporation and learn about the technology’s benefits for ex vivo genetic modification in cell and gene therapy manufacturing. 

Watch this 60-min roundtable discussion and join our expert panel as they discuss challenges, promising tools, trends and the future of CAR-T therapies.

In this webinar, Walter Bagni shares Lonza's approach digitalizing our cell therapy manufacturing operations and the future plans for the MODA-ES^® System within Lonza.

Join leading cell therapy thought leaders as they share their insights and lessons learned on advancing therapies from bench to bedside, the challenges they face, and where in their view the fast-evolving cell therapy field is heading.

Presented by CAR-TCR Digital Week

Learn from Senior Scientist Jerome Jacques how Lonza's new TheraPEAK^® SfAAV^® Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

Learn about CRISPR from discovery to cell and gene therapies, covering topics such as finding therapeutic pathways or process development considerations for bringing gene edited therapies to the clinic.

Presented by GEN

Learn about the latest advances and outstanding challenges in the fast paced research environment of CARs with experts that bridge the lab and clinic.

Presented by Nature Biotechnology

Learn more about the most promising approaches to cancer immunotherapy.

Presented by Nature Immunology and Nature Reviews Immunology

Learn from Senior Scientist Jerome Jacques how Lonza's new TheraPEAK^® SfAAV^® Medium can help to streamline and accelerate the production of AAV in Sf9 cells.

Learn about CRISPR from discovery to cell and gene therapies, covering topics such as finding therapeutic pathways or process development considerations for bringing gene edited therapies to the clinic.

Presented by GEN

Over the last few years, CRISPR/Cas9 has emerged as the genome editing method of choice. Explore the full CRISPR potential and hear about best practices to achieve optimal delivery results.

Learn about strategies for using CRIPSR/Cas9 for curing genetic diseases, and the impact on next generation disease model systems and drug screening. 

Presented by GEN

Get useful transfection tips and learn what factors may impact your transfection results when using the Nucleofector^TM Technology.

This webinar introduces the Nucleofector^TM Technology as an efficient, convenient and cost-effective, non-viral alternative for iPSC generation. 

Learn about the latest advances and outstanding challenges in the fast paced research environment of CARs with experts that bridge the lab and clinic.

Presented by Nature Biotechnology

In this talk, learn in vitro approaches to identify mechanisms of idiosyncratic drug-induced liver injury (IDILI) and emerging systems to investigate genetic risk factors.

Dr. Stephen Ferguson, a leading researcher at the National Institute of Environmental Health Sciences (NIEHS), discusses how liver cells assembled in 3D spheroids produce highly differentiated functionality and utility for toxicology screening.

Join our webinar to enhance your knowledge and skills in the realm of QC data integrity for endotoxin testing.

Learn about the immediate benefits of implementing PyroGene^® rFC in your lab.

Webinar attendees will learn how to increase efficiencies in the QC lab by incorporating sustainable solutions for testing, automation and digitalization.

You will learn about the responsibilities of a Contract Test Lab (CTL) and it's sponsor for pyrogen and endotoxins testing of various classes of parenteral products. Testing requirements and procedures, including how to overcome assay interferences, will be discussed.

Webinar attendees will learn what biologic products are, how they are tested for endotoxin content and how to overcome assay interferences.

This webinar describes to the customer the criticality of testing vaccines for the presence of endotoxin, and how those testing procedures are carried out.

As a leading developer, manufacturer and user of bacterial endotoxins test (BET) solutions, Lonza can fulfill your need for efficient, compliant and sustainable endotoxin testing. This webinar will discuss how automation of your BET program using the Lonza PyroTec^TM PRO Robotic System, integrated with our robust WinKQCL^TM Analysis and Detection Software, streamlines your testing program for the long run.

Learn about the essentials of testing medical devices for endotoxin, including updates released by the USP and the requirement for suitability testing.

Explore the new regulatory landscape for rFC and MAT as the assays gain global approval. rFC and MAT are no longer the 'alternatives'.

Learn how automating the liquid handling aspect of the endotoxin test helps you save time and reduce manual pipetting errors and retests.

Learn about what LAL manufacturers are doing to help solve the Low Endotoxin Recovery (LER) mystery. 

Learn how to tackle common forms of interference associated with endotoxin detection assays, and get the latest update on LER.

Learn how to establish endotoxin limits, validate the use of the Bacterial Endotoxins Test (BET) and establish procedures for routine testing.

Learn more about the PyroGene^TM rFC Assay, our animal-free method for endotoxin detection.

Hear from Phanesh Koneru, CEO of Exela^® Pharma Sciences, on why MES was important to him and Exela^®.

Webinar attendees will learn how to increase efficiencies in the QC lab by incorporating sustainable solutions for testing, automation and digitalization.

Join our panel of experts who discuss and share their experiences of recent MES implementations.

In this webinar, Walter Bagni shares Lonza's approach digitalizing our cell therapy manufacturing operations and the future plans for the MODA-ES^® System within Lonza.

Learn how to select and implement an electronic log solution that will replace paper and maximize your productivity.
 

Learn how Lonza collaborated with Nephron Pharmaceuticals, a leading pharmaceutical manufacturer to develop and implement the MODA-ES^TM Electronic Batch Record Platform in an accelerated timeframe of 9 months.

Learn from this case study how Adaptimmune, a leader in developing T cell cancer therapies, implemented Lonza's paperless MODA^® Solution to manage information in their QC micro lab more efficiently.

Learn how to integrate devices and systems in QC and production.

This webinar discusses how to build a compelling business case for implementing a Paperless QC Micro Solution.

Watch our webinar to learn how full integration of LIMS and the MODA-EM^TM Solution provides benefits to pharmaceutical quality control.

During this webinar you learn how to integrate device and consumables data with your lab compliance activities using the MODA^TM Solution.

The webinar discusses how the analytical tools of the MODA^TM Solution improve the speed and quality of excursion and adverse trend analysis.

Learn about regulatory expectations and data integrity in the QC Micro Lab and how they can be attained through automation.